Skip navigation

Ameridose in Mass. to remain closed through year

A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year. Full story

Affiliate of meningitis-linked firm initiates mass layoffs

BOSTON (Reuters) - Ameridose LLC, an affiliate of the New England Compounding Center at the heart of the deadly U.S. meningitis outbreak, is laying off about 90 percent of its workforce. Full story

Affiliate of US meningitis-linked firm extends shutdown

BOSTON (Reuters) - Ameridose LLC, sister company to the pharmacy at the heart of a meningitis outbreak in the United States, agreed on Friday to extend its closure by two weeks while state and federal investigators continue to examine its facilities. Full story

Sister company to meningitis-linked firm extends shutdown

(Reuters) - Ameridose LLC, sister company to the pharmacy at the heart of the U.S. meningitis outbreak, will extend its shutdown by an additional two weeks, under an agreement between the company and Massachusetts regulators. Full story

Huge drug recall latest fallout in deadly meningitis outbreak

BOSTON (Reuters) - Ameridose, a sister company of the U.S. pharmacy linked to a meningitis outbreak that has killed 29 people, announced on Wednesday a voluntary recall of all its products, a move to cooperate with regulators that could nevertheless create shortages of some drugs. Full story

Ameridose agrees to extend shutdown amid meningitis probe

BOSTON (Reuters) - Ameridose LLC, sister company to the New England Compounding Center at the heart of the U.S. meningitis outbreak, said on Friday it has agreed to extend a temporary shutdown while state and federal regulators continue an investigation into the company. Full story

Sponsored Links
advertisement | ad info